Table 1 Characteristics of the eligible studies that were assessed for various outcomes (n = 17)
Study name | Year | Country/Study location | Total sample size at baseline | Age in years (Range) | Gender | Characteristics of patients | Follow up time |
|---|---|---|---|---|---|---|---|
Shorook Na'ara et al. [21] | 2020 | Haifa, Israel | 58 | 1.2 to 15 | M:58.6% F: 41.3% | Breating and sleeping problems | 1 to 12Â months |
Secaattin Gu ̈ls et al. [3] | 2019 | Yozgat, Turkey | 72 | 5 to 11 | M: 50% F: 50% | Nasal airway obstruction with chronic postnasal discharge | 1 to 7 days |
Saroo Singh et al. [8] | 2019 | New Delhi, India | 60 | 6 to 12 | M: 78.3% F: 21.6% | Adenoid hypertrophy | 3Â months |
Juneja et al. [10] | 2018 | New Delhi, India | 50 | 5 to 12 | M: 70% F: 30% | Nasal or aural symptoms due to adenoid hypertrophy | 1Â day to 3Â months |
Mularczyk et al. [23] | 2018 | Illinois,USA | 101 |  < 18 years | NR | Adenoid hypertrophy | 3 days |
Hussein and Al-Juboori [36] | 2012 | Hilla, Iraq | 40 | 4 to 20 | M: 40% F: 60% | Nasal airway obstruction with sleep disordered breathing, epistaxis, discharge, and otological symptoms | Post-operative period (short follow-up): Exact duration NR |
Baker et al. [28] | 2012 | Virginia, USA | 61 | 1 to 12 | M: 60.6% F: 39.3% | Adenoid hypertrophy | Post-operative period (short follow-up): Exact duration NR |
Öztürket al [29] | 2012 | Istanbul, Turkey | 56 | 1.8 to 15.6 | M:54.7% F: 45.3% | Nasal airway obstruction with sleep disordered breathing and otitis media and chronic rhinosuinitis | 6 months |
Bradoo et al. [37] | 2011 | Mumbai, India | 32 | 5 ot 13 | M:54.8% F: 45.2% | Mouth breathing, adenooid facies, ear problems, and saliva drooling | 3Â months |
Songu et al. [30] | 2010 | Izmir, Turkey | 38 | 8 to 12 | M:52.6% F: 47.3% | Adenoid hypertrophy | 3Â months |
Datta et al. [24] | 2009 | Mumbai, India | 60 | 6 to 12 | NR | Adenoid hypertrophy | 1 to 7Â days |
Al-Mazrou et al. [27] | 2009 | Riyadh, Saudi Arabia | 40 | 3 to 17 | M: 50% F: 50 | Snoring, obstructive sleep apnea and enlarged adenoids | 3 to 24Â months |
Jonas et al. [3] | 2007 | Cape Town, South Africa | 100 | 1.2Â months to 13Â years | M: 49% F: 51% | Snoring, obstructive sleep apnea, nasal airway obstruction, chronic otitis media, and enlarged adenoids | 6Â months |
Shapiro et al. [25] | 2007 | California, USA | 47 | 2 to 16 | M: 59.5% F: 38.3% | Adenoid hypertrophy | 14Â days |
Tarantino et al. [26] | 2004 | Genova, Italy | 600 | 2 to 10 | NR | nasal airway obstruction, nasal dyspnea, noisy breathing, otitis media, and hearing loss | Post-operative period (short follow-up): Exact duration NR |
Stanislaw et al. [31] | 2000 | New York, USA | 177 | 1 to 13 | M: 57.6% F: 42.3% | Adenoid hypertrophy | 1 to 7Â days |
Clemens et al. [32] | 1997 | USA | 34 | 4.9 ± 2.8 and 6.9 ± 4.1 | NR | Adenoid hypertrophy | 1 month |